New Horizons and Current Concepts in Cardiac Computed Tomography

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 8450

Special Issue Editors


E-Mail Website
Guest Editor
Department of Internal Medicine III (Cardiology), Medizinische Universität Innsbruck, Innsbruck, Austria
Interests: cardiac electrophysiology; takotsubo syndrome; cardiac computed tomography; sleep apnea

E-Mail Website
Guest Editor
Department of Radiology, Medizinische Universität Innsbruck, Innsbruck, Austria
Interests: coronary CTA; coronary artery disease; computed tomography angiography
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiac imaging has evolved rapidly over the past decades. Multi-slice computed tomography (CT) is now the preferred imaging modality for non-invasive diagnosis of coronary artery disease. Detection of high-risk coronary plaques allows for improved selection of patients at high risk for future major clinical events. Furthermore, other structures of the heart such as valve morphology, the amount of valvular calcification, and the characteristics of cardiac chambers including the left atrial appendage (size, wall thickness), epicardial fat, embolic sources (thrombus, endocarditis) and extra-cardiac vessels can be assessed. Cardiac CT plays a key role in guiding cardiovascular interventions such as transcatheter aortic valve implantation, pulmonary vein isolation, or left atrial appendage occlusion.

We are inviting original research articles and reviews (state-of-the-art and novel clinical applications) to be submitted until 31th December 2021.

Dr. Wolfgang Dichtl
Prof. Dr. Gudrun Feuchtner
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • structural heart disease
  • cardiac imaging
  • high-risk plaque
  • atherosclerosis
  • coronary artery disease
  • valvular calcification
  • thrombus detection

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

4 pages, 202 KiB  
Editorial
Cardiac Computed Tomography: State of the Art and Future Horizons
by Gudrun M. Feuchtner, Fabian Plank, Christoph Beyer, Fabian Barbieri, Gerlig Widmann, Philipp Spitaler and Wolfgang Dichtl
J. Clin. Med. 2022, 11(15), 4429; https://doi.org/10.3390/jcm11154429 - 29 Jul 2022
Cited by 3 | Viewed by 1323
Abstract
Cardiac computed tomography (CT) has evolved over the past 20 years from an alternative, promising noninvasive imaging modality to a Class I indication for the non-invasive evaluation of patients with low-to-intermediate, pre-test probability of coronary artery disease (CAD), as per the European Society [...] Read more.
Cardiac computed tomography (CT) has evolved over the past 20 years from an alternative, promising noninvasive imaging modality to a Class I indication for the non-invasive evaluation of patients with low-to-intermediate, pre-test probability of coronary artery disease (CAD), as per the European Society of Cardiology (ESC) guidelines published in 2019 [...] Full article
(This article belongs to the Special Issue New Horizons and Current Concepts in Cardiac Computed Tomography)

Research

Jump to: Editorial, Review

6 pages, 977 KiB  
Article
Bicuspid Aortic Valve Is Associated with Less Coronary Calcium and Coronary Artery Disease Burden
by Gudrun Feuchtner, Sven Bleckwenn, Leon Stoessl, Fabian Plank, Christoph Beyer, Nikolaos Bonaros, Thomas Schachner, Thomas Senoner, Gerlig Widmann, Can Gollmann-Tepeköylü, Johannes Holfeld, Wolfgang Dichtl and Fabian Barbieri
J. Clin. Med. 2021, 10(14), 3070; https://doi.org/10.3390/jcm10143070 - 11 Jul 2021
Cited by 3 | Viewed by 2236
Abstract
(1) Background. Bicuspid aortic valve (BAV) is associated with genetic defects (NOTCH 1, GATA 5) and aortopathy. Differences in the flow patterns and a genetic predisposition could also affect coronary arteries. The objective was to assess the coronary artery calcium score (CACS) and [...] Read more.
(1) Background. Bicuspid aortic valve (BAV) is associated with genetic defects (NOTCH 1, GATA 5) and aortopathy. Differences in the flow patterns and a genetic predisposition could also affect coronary arteries. The objective was to assess the coronary artery calcium score (CACS) and coronary artery disease (CAD) burden by coronary computed tomography angiography (CTA) in patients with BAV stenosis, as compared to stenotic tricuspid aortic valves (TAV). (2) Methods. A retrospective case–control study. A total of 47 patients with BAV stenosis (68.9 years ± 12.9, 38.3% females) who underwent CTA were matched with 47 TAV stenosis patients for age, gender, smoking, arterial hypertension, dyslipidemia, diabetes, body-mass-index and chronic kidney disease. (3) Results. The coronary artery calcium score (CACS) was lower in BAV (237.4 vs. 1013.3AU; p < 0.001) than in TAV, and stenosis severity was less (CAD-RADTM: p < 0.001). More patients with BAV had CACS zero (27.7% vs. 0%; p < 0.001). The majority (68.1%) of patients with BAV had no or non-obstructive CAD but only 25.5% of TAV (p < 0.001). Obstructive CAD (>50% stenosis) by CTA was more frequently observed in patients with TAV (68.1%; p < 0.001). (4) Conclusions and Relevance. Patients with BAV stenosis have markedly less coronary calcium and less severe coronary stenosis. CTA succeeds to rule out obstructive CAD in the majority of BAV, with adherent implications for TAVR planning. Full article
(This article belongs to the Special Issue New Horizons and Current Concepts in Cardiac Computed Tomography)
Show Figures

Figure 1

13 pages, 908 KiB  
Article
Gender Differences in the Atherosclerosis Profile by Coronary CTA in Coronary Artery Calcium Score Zero Patients
by Thomas Senoner, Fabian Plank, Christoph Beyer, Christian Langer, Katharina Birkl, Fabian Steinkohl, Gerlig Widmann, Fabian Barbieri, Agne Adukauskaite, Guy Friedrich, Axel Bauer, Wolfgang Dichtl and Gudrun M. Feuchtner
J. Clin. Med. 2021, 10(6), 1220; https://doi.org/10.3390/jcm10061220 - 15 Mar 2021
Cited by 9 | Viewed by 2094
Abstract
Background: The coronary artery calcium score (CACS) is a powerful tool for cardiovascular risk stratification. Coronary computed tomography angiography (CTA) allows for a more distinct analysis of atherosclerosis. The aim of the study was to assess gender differences in the atherosclerosis profile [...] Read more.
Background: The coronary artery calcium score (CACS) is a powerful tool for cardiovascular risk stratification. Coronary computed tomography angiography (CTA) allows for a more distinct analysis of atherosclerosis. The aim of the study was to assess gender differences in the atherosclerosis profile of CTA in patients with a CACS of zero. Methods: A total of 1451 low- to intermediate-risk patients (53 ± 11 years; 51% females) with CACS <1.0 Agatston units (AU) who underwent CTA and CACS were included. Males and females were 1:1 propensity score-matched. CTA was evaluated for stenosis severity (Coronary Artery Disease – Reporting and Data System (CAD-RADS) 0–5: minimal <25%, mild 25–49%, moderate 50–69%, severe ≥70%), mixed-plaque burden (G-score), and high-risk plaque (HRP) criteria (low-attenuation plaque, spotty calcification, napkin-ring sign, and positive remodeling). All-cause mortality, cardiovascular mortality, and major cardiovascular events (MACEs) were collected. Results: Among the patients, 88.8% had a CACS of 0 and 11.2% had an ultralow CACS of 0.1–0.9 AU. More males than females (32.1% vs. 20.3%; p < 0.001) with a CACS of 0 had atherosclerosis, while, among those with an ultralow CACS, there was no difference (88% vs. 87.1%). Nonobstructive CAD (25.9% vs. 16.2%; p < 0.001), total plaque burden (2.2 vs. 1.4; p < 0.001), and HRP were found more often in males (p < 0.001). After a follow-up of mean 6.6 ± 4.2 years, all-cause mortality was higher in females (3.5% vs. 1.8%, p = 0.023). Cardiovascular mortality and MACEs were low (0.2% vs. 0%; p = 0.947 and 0.3% vs. 0.6%; p = 0.790) for males vs. females, respectively. Females were more often symptomatic for chest pain (70% vs. 61.6%; p = 0.004). (4) Conclusions: In patients with a CACS of 0, males had a higher prevalence of atherosclerosis, a higher noncalcified plaque burden, and more HRP criteria. Nonetheless, females had a worse long–term outcome and were more frequently symptomatic. Full article
(This article belongs to the Special Issue New Horizons and Current Concepts in Cardiac Computed Tomography)
Show Figures

Figure 1

Review

Jump to: Editorial, Research

15 pages, 2108 KiB  
Review
Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)
by Luz Kelly Anzola, Jose Nelson Rivera, Juan Carlos Ramirez, Alberto Signore and Fernando Mut
J. Clin. Med. 2021, 10(23), 5515; https://doi.org/10.3390/jcm10235515 - 25 Nov 2021
Cited by 7 | Viewed by 2088
Abstract
Atherosclerosis is responsible for the majority of heart attacks and is characterized by several modifications of the arterial wall including an inflammatory reaction. The silent course of atherosclerosis has made it necessary to develop predictors of disease complications before symptomatic lesions occur. Vulnerable [...] Read more.
Atherosclerosis is responsible for the majority of heart attacks and is characterized by several modifications of the arterial wall including an inflammatory reaction. The silent course of atherosclerosis has made it necessary to develop predictors of disease complications before symptomatic lesions occur. Vulnerable to rupture atherosclerotic plaques are the target for molecular imaging. To this aim, different radiopharmaceuticals for PET/CT have emerged for the identification of high-risk plaques, with high specificity for the identification of the cellular components and pathophysiological status of plaques. By targeting specific receptors on activated macrophages in high-risk plaques, radiolabelled somatostatin analogues such as 68Ga-DOTA-TOC, TATE,0 or NOC have shown high relevance to detect vulnerable, atherosclerotic plaques. This PET radiopharmaceutical has been tested in several pre-clinical and clinical studies, as reviewed here, showing an important correlation with other risk factors. Full article
(This article belongs to the Special Issue New Horizons and Current Concepts in Cardiac Computed Tomography)
Show Figures

Figure 1

Back to TopTop